Does continuous positive airway pressure (CPAP) reduce cardiovascular disease (CVD) or mortality in patients with obstructive sleep apnea?
There is a lack of convincing evidence that CPAP reduces CVD or mortality in patients with moderate-to-severe obstructive sleep apnea. Adherence to CPAP treatment in most clinical trials is low (1.4-5.8 hours/night at one year). Modest clinically important improvements in daytime sleepiness have been demonstrated. Quality of life scales have also demonstrated improvement^ although clinical significance is unclear.
Publication Date: 2018-8-20
Last Updated on PCR: 2018-08-23 11:05:54